Revolution Medicines
Highly Engaged Employees
Business Services · California, United States · 501-1,000 Employees
View Company Info for Free
Overview
Headquarters
700 Saginaw Dr, Redwood City, California...Phone Number
(844) 273-8633Website
www.revmed.comRevenue
-Stock Symbol
RVMDIndustry
About Revolution Medicines
Revolution Medicines Org Chart
Is Revolution Medicines your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Funding: Get notified immidiatlly once Revolution Medicines has new funding data
Earning: See what the market has to say on Revolution Medicines recently announced quarterly report
Click to see if Revolution Medicines had a recent Job posting/layoffs
Revolution Medicines, which may be a good buyer, showed buying intent in Masked Content Topic
Check out if Revolution Medicines is spiking on competitors!
Website visits: Recent activity has been detected on your website
Congratulate Masked Content for being promoted to Masked Content at Revolution Medicines
Product Launch: Get notified when Revolution Medicines launches new products
Check if Revolution Medicines has recently received funding, and reach out quickly before it becomes old news!
Recommended Actions
Reach out to Masked Content who joined Revolution Medicines as Masked Content
Find 3 more new buyers
Compare Similar Companies to Revolution Medicines
Compare insights from companies similar to Revolution Medicines, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
Company Profile Activity
Activity Insights
Revolution Medicines is experiencing very low activity levels compared to other companies in the Manufacturing sector.
What does this means?
Revolution Medicines is drawing exceptional interest within the Manufacturing industry, suggesting notable developments or strong market momentum, learn more about Revolution Medicines.
Revolution Medicines financials insights
Gather financial insights about Revolution Medicines, including details on funding rounds, investors, total funding, and acquisitions, to gain a comprehensive understanding of their financial strategy.
Series A
$25M
Series B
$56M
Stock Offering
$238M
Stock Offering
$260.9M
Revolution Medicines Tech Stack
A closer look at the technologies used by Revolution Medicines
Most Recent Scoops
Revolution Medicines News & Media
Billionaire Stanley Druckenmiller Continues to Load Up on Revolution Medicines. Does He Know Something Wall Street Doesn't?
One of the most successful investors ever really likes this up-and-coming biotech stock.Why Revolution Medicines May Be Big Pharma’s Next Takeover Target
RAS mutations fuel nearly a third of all cancers, and one biotech has quietly built the deepest late-stage pipeline targeting them. Now the biggest names in pharma are circling, and the math on who can actually write the check gets complicated fast.Propanc Biopharma Highlights Differentiated Proenzyme Therapy PRP as a Potential Therapy of Choice Against RAS-Driven Cancers
Further improvements can be made with complementary treatment modalities such as PRP that target the way cancer cells become malignant, invasive and spreadCan Revolution Medicines (RVMD) Turn A New Ally Into Global Reach?
Revolution Medicines (NASDAQ:RVMD) just picked up a partner with deep pockets and a presence across Asia. On August 10, the company announced a multi-part collaboration with BeOne Medicines, pairing clinical development with a regional rights deal. For a stock that has already climbed more than 400% over the past year, the question is whether this […]
Top Business Services Companies
Top companies in Canada by revenue
Top companies in Australia by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding Revolution Medicines
Revolution Medicines is a biopharmaceutical company focused on discovering, developing, and delivering targeted therapies for patients with RAS-driven cancers. The company develops innovative RAS(ON) inhibitors using its proprietary tri-complex technology platform, advancing a pipeline of precision oncology medicines through clinical development.... Read More
